PAR News: PARADIGM BIOPHARMACEUTICALS LTD. APPOINTS MARCO POLIZZI as CHIEF EXECUTIVE OFFICER - 28th Jun 2022, 4:00am

annb0t

Top 20
Polizzi Possesses More Than 30 Years of Experience in the Pharmaceutical Industry.

NEW YORK, June 27, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing existing molecules for new indications with unmet clinical needs, appointed experienced pharmaceutical industry executive Marco Polizzi as its full-time Chief Executive Officer (CEO), effective July 1, 2022. Paradigm Biopharma (PRNewsfo...

>>> Read more: PARADIGM BIOPHARMACEUTICALS LTD. APPOINTS MARCO POLIZZI as CHIEF EXECUTIVE OFFICER
 
Top Bottom